to study search History No further version available for comparison

Psycho-biological treatment effects of trauma-focused art therapy in patients with psychological and physical trauma consequences

Organizational Data

DRKS-ID:
DRKS00022989
Recruitment Status:
Recruiting planned
Date of registration in DRKS:
2020-09-08
Last update in DRKS:
2020-09-08
Registration type:
Prospective

Acronym/abbreviation of the study

MALT!

URL of the study

No Entry

Brief summary in lay language

The study examines the psychological and biological stress reaction of patients directly after a stressful life event. The aim is to examine, how patients react to a stress stimulus and to what extent art therapy can influence this reaction and reduce the probability of post-traumatic stress disorder

Brief summary in scientific language

The study examines the psychological and biological stress reaction of patients directly after a stressful life event. It will be examined how patients react to an external stress stimulus and to what extent an art therapy offer after the traumatic event influences this reaction and reduces the probability of occurrence of post-traumatic stress disorder.

Health condition or problem studied

ICD10:
F43.0 - Acute stress reaction
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Art Therapy Intervention The patients receive art therapy over 8 sessions in the course of approx. 3 months and will then be invited for a follow-up examination
Arm 2:
Watchful Waiting Control The patients do not receive an art therapy offer and are invited for a follow-up examination after about 3 months.

Endpoints

Primary outcome:
The primary objective is the severity of posttraumatic stress symptoms after the intervention, measured with the revised version of the Impact of Events Scale (IES-R) (Maercker & Schützwohl, 1998; Weiss & Marmar, 1997) and the German version of the Posttraumatic Diagnostic Survey (PDS)(Ehlers et al., 1996).
Secondary outcome:
Secondary biological targets are neuroendocrine and immunological stress reactivity (measured by cortisol and α-amylase in saliva, and interleukin (IL)-6 and IL-10 in plasma), stress-related DNA damage in single cells in the form of single- and double-strand breaks, and their metabolites (including nitrotyrosine/HO-1/iNOS) by exposure to stress-related radical formation. Secondary psychicological targets are depression and post-traumatic growth. Translated with www.DeepL.com/Translator (free version)

Study Design

Purpose:
Prevention
Allocation:
Randomized controlled study
Control:
  • Control group receives no treatment
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
Yes
Assignment:
Factorial
Sequence generation:
No Entry
Who is blinded:
  • Investigator/therapist

Recruitment

Recruitment Status:
Recruiting planned
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • Medical center Klinikum Nürnberg Nürnberg

Recruitment period and number of participants

Planned study start date:
2020-09-27
Actual study start date:
No Entry
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
128
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
Female
Minimum Age:
18 Years
Maximum Age:
50 Years
Additional Inclusion Criteria:
Recruitment of patients after potentially traumatizing, critical events that have an increased risk of developing post-traumatic stress disorder Critical events are defined as: a) miscarriage or stillbirth b) Incisive cardiac event (e.g. myocardial infarction, resuscitation after cardiac event, aortic dissection) c) Serious accident (e.g. traffic accident)

Exclusion Criteria

- Male sex - Acute addiction - Acute suicidal tendency - Mental disorders that require permanent medication - Chronic inflammatory diseases with anti-inflammatory medication - Dementia - Insufficient knowledge of the german language - Non-accessibility of the Klinikum Nürnberg from your place of residence (for outpatient therapy sessions)

Addresses

Primary Sponsor

Address:
Ärztliche Leitung der Klinik fürPsychosomatische Medizin und PsychotherapieKlinikum Nürnberg
Prof. Dr. med Christiane Waller
Prof.-Ernst-Nathan-Straße 1
90419 Nürnberg
Germany
Telephone:
0911 398 - 2839
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.klinikum-nuernberg.de/DE/ueber_uns/Fachabteilungen_KN/kliniken/psychosomatik/MA_Waller.html
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Ärztliche Leitung der Klinik für Psychosomatische Medizin und PsychotherapieKlinikum Nürnberg
Prof. Dr. med Christiane Waller
Prof.-Ernst-Nathan-Straße 1
90419 Nürnberg
Germany
Telephone:
0911 398 - 2839
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.klinikum-nuernberg.de/DE/ueber_uns/Fachabteilungen_KN/kliniken/psychosomatik/MA_Waller.html

Contact for Public Queries

Address:
Ärztliche Leitung der Klinik für Psychosomatische Medizin und PsychotherapieKlinikum Nürnberg
Prof. Dr. med Christiane Waller
Prof.-Ernst-Nathan-Straße 1
90419 Nürnberg
Germany
Telephone:
0911 398 - 2839
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.klinikum-nuernberg.de/DE/ueber_uns/Fachabteilungen_KN/kliniken/psychosomatik/MA_Waller.html

Principal Investigator

Address:
Ärztliche Leitung der Klinik für Psychosomatische Medizin und PsychotherapieKlinikum Nürnberg
Prof. Dr. med Christiane Waller
Prof.-Ernst-Nathan-Straße 1
90419 Nürnberg
Germany
Telephone:
0911 398 - 2839
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.klinikum-nuernberg.de/DE/ueber_uns/Fachabteilungen_KN/kliniken/psychosomatik/MA_Waller.html

Sources of Monetary or Material Support

Private sponsorship (foundations, study societies, etc.)

Address:
STAEDTLER Stiftung
Moosäckerstraße 3
90427 Nürnberg
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.staedtler.com/de/de/stiftung/

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission der Medizinischen Fakultät der Universität Erlangen-Nürnberg
Krankenhausstr. 12
91054 Erlangen
Germany
Telephone:
+40-9131-8522270
Fax:
+49-9131-8526021
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2019-05-03
Ethics committee number:
121_19 B
Vote of the Ethics Committee:
Approved
Date of the vote:
2019-05-27

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry